China Pharma Holdings (CPHI)
(Delayed Data from AMEX)
$0.22 USD
0.00 (-0.50%)
Updated Sep 20, 2024 03:55 PM ET
After-Market: $0.21 -0.01 (-3.98%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
CPHI 0.22 0.00(-0.50%)
Will CPHI be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CPHI based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for CPHI
China Pharma Holdings, Inc. expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025
China Pharma expects to launch dry eye disease therapeutic device in Q1
China Pharma subsidiary plans to launch dry eye treatment in Q1 of 2025 in China
CPHI Stock Earnings: China Pharma Holding Reported Results for Q2 2024